OMEROS CORP Contracts & Agreements

Sixteenth Amendment to Lease dated July 8, 2024 between Omeros Corporation and BMR-201 Elliott Avenue LLC (Filed With SEC on November 13, 2024)

Fifteenth Amendment to Lease dated November 1, 2022 between Omeros Corporation and BMR-201 Elliott Avenue LLC (Filed With SEC on August 7, 2024)

Credit and Guaranty Agreement, dated as of June 3, 2024, among the Company, certain subsidiaries of the Company, as guarantors, various Lenders and Wilmington Savings Fund... (Filed With SEC on June 3, 2024)

Pledge and Security Agreement, dated as of June 3, 2024, between the Company, nura inc. and Wilmington Savings Fund Society, FSB, as Collateral Agent (Filed With SEC on June 3, 2024)

License Agreement between Omeros Corporation and Daiichi Sankyo Co., Ltd. (successor-in-interest to Asubio Pharma Co., Ltd.) dated March 3, 2010 (Filed With SEC on April 1, 2024)

Amendment No. 1 to License Agreement with an effective date of January 5, 2011 between Omeros Corporation and Daiichi Sankyo Co., Ltd (Filed With SEC on April 1, 2024)

Amendment No. 2 to License Agreement with an effective date of January 25, 2013 between Omeros Corporation and Daiichi Sankyo Co., Ltd (Filed With SEC on April 1, 2024)

Amended and Restated Royalty Purchase Agreement between Omeros Corporation and DRI Healthcare Acquisitions LP dated February 1, 2024 (Filed With SEC on April 1, 2024)

Technology License Agreement, effective August 28, 2020 between Omeros Corporation and Xencor, Inc (Filed With SEC on March 13, 2023)

Omeros Corporation Non-Employee Director Compensation Policy (Filed With SEC on March 13, 2023)

Royalty Purchase Agreement dated September 30, 2022 between Omeros Corporation and DRI Healthcare Acquisitions LP (Filed With SEC on November 9, 2022)

Fourteenth Amendment to Lease dated January 14, 2022 between Omeros Corporation and BMR-201 Elliott Avenue LLC (Filed With SEC on May 10, 2022)

Asset Purchase Agreement, dated as of December 1, 2021 among Omeros Corporation, Rayner Surgical Inc. and Rayner Surgical Group, Limited, as Parent Guarantor (Filed With SEC on March 1, 2022)

Consent and Second Amendment to Loan and Security Agreement, dated as of December 1, 2021, by and between Omeros Corporation and Silicon Valley Bank (Filed With SEC on March 1, 2022)

Master Service Agreement dated July 28, 2019, as amended, between Omeros Corporation and Lonza Biologics Tuas Pte Ltd (Filed With SEC on November 9, 2021)

Thirteenth Amendment to Lease dated June 1, 2021 between Omeros Corporation and BMR-201 Elliott Avenue LLC (Filed With SEC on August 9, 2021)

Omeros Corporation 2017 Omnibus Incentive Compensation Plan (as amended and restated effective June 11, 2021) (Filed With SEC on June 16, 2021)

Sales Agreement, dated March 1, 2021, between Omeros Corporation and Cantor Fitzgerald & Co (Filed With SEC on March 1, 2021)

Description of Common Stock (Filed With SEC on March 1, 2021)

Omeros Corporation Non-Employee Director Compensation Policy (Filed With SEC on March 1, 2021)

Eleventh Amendment to Lease dated October 23, 2020 between Omeros Corporation and BMR-201 Elliott Avenue LLC (Filed With SEC on March 1, 2021)

Twelfth Amendment to Lease dated January 1, 2021 between Omeros Corporation and BMR-201 Elliott Avenue LLC (Filed With SEC on March 1, 2021)

Tenth Amendment to Lease Agreement, dated September 15, 2020, by and between Omeros Corporation and BMR-201 Elliott Avenue LLC (Filed With SEC on November 9, 2020)

Underwriting Agreement, dated as of August 11, 2020, between Omeros Corporation and BofA Securities, Inc. and J.P. Morgan Securities LLC, as representatives of the Equity... (Filed With SEC on August 14, 2020)

Underwriting Agreement, dated as of August 11, 2020, between Omeros Corporation and BofA Securities, Inc. and J.P. Morgan Securities LLC, as representatives of the Notes... (Filed With SEC on August 14, 2020)

Indenture, dated as of August 14, 2020, between Omeros Corporation and Wells Fargo Bank, National Association, as trustee (Filed With SEC on August 14, 2020)

First Supplemental Indenture, dated as of August 14, 2020, between Omeros Corporation and Wells Fargo Bank, National Association, as trustee (Filed With SEC on August 14, 2020)

Form of Capped Call Transaction Confirmation (Filed With SEC on August 14, 2020)

First Amendment to Loan and Security Agreement, dated as of August 7, 2020, by and between Omeros Corporation and Silicon Valley Bank (Filed With SEC on August 10, 2020)

Ninth Amendment to Lease dated January 15, 2020 between Omeros Corporation and BMR-201 Elliott Avenue LLC (Filed With SEC on May 11, 2020)

Consulting Agreement effective February 10, 2020 between Omeros Corporation and Kurt Zumwalt (Filed With SEC on May 11, 2020)

Description of Common Stock (Filed With SEC on March 2, 2020)

Eighth Amendment to Lease dated October 18, 2019 between Omeros Corporation and BMR-201 Elliott Avenue LLC (Filed With SEC on March 2, 2020)

Underwriting Agreement, dated December 5, 2019, between Omeros Corporation and Cantor Fitzgerald & Co (Filed With SEC on December 6, 2019)

Master Services Agreement, dated July 28, 2019, between Omeros Corporation and Lonza Biologics Tuas Pte. Ltd (Filed With SEC on November 12, 2019)

Seventh Amendment to Lease, dated April 15, 2019, between Omeros Corporation and BMR-201 Elliott Avenue LLC (Filed With SEC on August 8, 2019)

Loan and Security Agreement by and between Omeros Corporation and Silicon Valley Bank, dated August 2, 2019 (Filed With SEC on August 8, 2019)

OMEROS CORPORATION 2017 Omnibus Incentive Compensation Plan (as amended and restated effective as of June 7, 2019) (Filed With SEC on June 11, 2019)

Sixth Amendment to Lease dated October 18, 2018 between Omeros Corporation and BMR-201 Elliott Avenue LLC (Filed With SEC on March 1, 2019)

Indenture, dated as of November 15, 2018, between Omeros Corporation and Wells Fargo Bank, National Association, as trustee (including the form of 6.25% Convertible Senior Notes... (Filed With SEC on November 15, 2018)

Purchase Agreement, dated November 8, 2018, among Omeros Corporation and Cantor Fitzgerald & Co. and UBS Securities LLC as the initial purchasers, relating to the Companys 6.25%... (Filed With SEC on November 15, 2018)

Form of capped call transaction confirmation, dated as of November 8, 2018, by and between Royal Bank of Canada and Omeros Corporation, in reference to the 6.25% Convertible... (Filed With SEC on November 15, 2018)

Settlement Agreement, dated as of May 22, 2018, by and among Omeros Corporation and Lupin Ltd. and Lupin Pharmaceuticals, Inc (Filed With SEC on May 24, 2018)

Third Amendment to Term Loan Agreement among Omeros Corporation, nura, inc., CRG Servicing LLC, as administrative agent and collateral agent, and certain lenders thereto, dated... (Filed With SEC on April 13, 2018)

Form of Warrant to Purchase Stock issued by Omeros Corporation to each lender (Filed With SEC on April 13, 2018)

Amendment No. 2 to Loan Agreement among Omeros Corporation, CRG Servicing LLC, as administrative agent and collateral agent, and the lenders named therein, dated February 26, 2018 (Filed With SEC on March 1, 2018)

Amendment No. 1 to Loan Agreement between among Omeros Corporation, CRG Servicing LLC, as administrative agent and collateral agent, and the lenders named therein, dated October... (Filed With SEC on October 17, 2017)

Settlement Agreement, dated October 4, 2017, by and among Omeros Corporation, Par Sterile Products, LLC and Par Pharmaceutical, Inc (Filed With SEC on October 5, 2017)

Underwriting Agreement, dated August 14, 2017, among Omeros Corporation and Cantor Fitzgerald & Co., as representative of the Underwriters (Filed With SEC on August 17, 2017)

Omeros Corporation Non-Employee Director Compensation Policy (Filed With SEC on August 8, 2017)

FIFTH AMENDMENT TO LEASE (Filed With SEC on May 10, 2017)

OMEROS CORPORATION 2008 EQUITY INCENTIVE PLAN (as amended December 13, 2016) (Filed With SEC on March 16, 2017)

OMEROS CORPORATION NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Filed With SEC on March 16, 2017)

Third Amendment to Pharmaceutical Manufacturing and Supply Agreement (Filed With SEC on March 16, 2017)

Second Amendment to Pharmaceutical Manufacturing and Supply Agreement (Filed With SEC on November 9, 2016)

TERM LOAN AGREEMENT dated as of October 26, 2016 among OMEROSCORPORATION, as Borrower, The Subsidiary Guarantors from Time to Time Party Hereto, The Lenders from Time to Time... (Filed With SEC on October 27, 2016)

SECURITY AGREEMENT dated as of October[], 2016 among OMEROS CORPORATION, The Other Grantors from Time to Time Party Hereto and CRG SERVICING LLC, as Administrative Agent and... (Filed With SEC on October 27, 2016)

OMEROS CORPORATION 3,478,260 Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on August 15, 2016)

FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on May 19, 2016)

FORM OF WARRANT TO PURCHASE STOCK (Filed With SEC on May 19, 2016)

PROJECT AGREEMENT (SALES OPERATIONS SERVICES for CLIENT SALES TEAMS) (Filed With SEC on March 15, 2016)

OMEROSCORPORATION Common Stock (par value $0.01 per share) AtMarket Issuance Sales Agreement (Filed With SEC on January 6, 2016)

LOAN AND SECURITY AGREEMENT (Filed With SEC on January 6, 2016)

FIRST AMENDMENT TO COMMERCIAL SUPPLY AGREEMENT (Filed With SEC on November 9, 2015)

First Amendment to Pharmaceutical Manufacturing and Supply Agreement (Filed With SEC on November 9, 2015)

FOURTH AMENDMENT TO LEASE (Filed With SEC on November 9, 2015)

LICENSE AGREEMENT (Filed With SEC on August 10, 2015)

RESEARCH AND DEVELOPMENT AGREEMENT EIGHTH AMENDMENT (Filed With SEC on March 16, 2015)

FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on March 16, 2015)

SECOND AMENDMENT TO PROJECT AGREEMENT (Detailing and Sales Operations Services) (Filed With SEC on March 16, 2015)

COMMERCIAL SUPPLY AGREEMENT (Filed With SEC on March 16, 2015)

OMEROSCORPORATION 2,995,506 Shares of Common Stock and Pre-Funded Warrants to Purchase 749,250 Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on February 2, 2015)

NOTICE OF WARRANT EXTENSION September 28, 2014 (Filed With SEC on September 29, 2014)

MASTER SERVICE AGREEMENT (Filed With SEC on August 11, 2014)

PROJECT AGREEMENT (DETAILING AND SALES OPERATION SERVICES) (Filed With SEC on August 11, 2014)

FIRST AMENDMENT TO PROJECT AGREEMENT (Detailing and Sales Operations Services) (Filed With SEC on August 11, 2014)

TABLE OF CONTENTS (Filed With SEC on May 12, 2014)

NOTICE OF WARRANT EXTENSION March 28, 2014 (Filed With SEC on April 3, 2014)

3,043,479 OMEROSCORPORATION Common Stock UNDERWRITING AGREEMENT (Filed With SEC on March 18, 2014)

THIRD AMENDMENT TO LEASE (Filed With SEC on March 13, 2014)

SETTLEMENT AGREEMENT AND RELEASE (Filed With SEC on March 13, 2014)

EIGHTH AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on March 13, 2014)

LOAN AND SECURITY AGREEMENT (Filed With SEC on March 7, 2014)

OMEROS CORPORATION 2008 EQUITY INCENTIVE PLAN NOTICE OF GRANT OF STOCK OPTION (Filed With SEC on November 7, 2013)

OMEROS CORPORATION SUBSCRIPTION AGREEMENT (Filed With SEC on May 10, 2013)

Amendment No. 2 to LICENSE AGREEMENT (Filed With SEC on May 9, 2013)

NOTICE OF WARRANT EXTENSION March 28, 2013 (Filed With SEC on March 29, 2013)

SECOND AMENDMENT TO LEASE (Filed With SEC on March 18, 2013)

FIRST AMENDMENT TO PATENT ASSIGNMENT AGREEMENT (Filed With SEC on March 18, 2013)

Amendment No. 2 to LICENSE AGREEMENT (Filed With SEC on March 18, 2013)

CONSENT AND FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on March 18, 2013)

THIRD AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on March 18, 2013)

FOURTH AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on March 18, 2013)

FIFTH AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on March 18, 2013)

SIXTH AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on January 2, 2013)

SECURED PROMISSORY NOTE (Tranche 3 Advance) (Filed With SEC on January 2, 2013)

ALLONGE TO SECURED PROMISSORY NOTE (CLOSING DATE ADVANCE) (Filed With SEC on January 2, 2013)

ALLONGE TO SECURED PROMISSORY NOTE (TRANCHE 2 ADVANCE) (Filed With SEC on January 2, 2013)

OMEROS CORPORATION Common Stock (par value $0.01 per share) At Market Issuance Sales Agreement (Filed With SEC on December 14, 2012)

FIRST AMENDMENT TO LEASE (Filed With SEC on November 9, 2012)

AMENDED AND RESTATED SETTLEMENT AGREEMENT AND RELEASE (Filed With SEC on November 1, 2012)

FOURTH AMENDMENT TO OFFICE LEASE AGREEMENT (Filed With SEC on September 28, 2012)

2,926,830 OMEROS CORPORATION Common Stock UNDERWRITING AGREEMENT (Filed With SEC on June 28, 2012)

NOTICE OF WARRANT EXTENSION March 28, 2012 (Filed With SEC on March 29, 2012)

LEASE by and between BMR-201 ELLIOTT AVENUE LLC, a Delaware limited liability company and OMEROS CORPORATION, a Washington corporation LEASE (Filed With SEC on February 1, 2012)

Amendment No. 1 to LICENSE AGREEMENT (Filed With SEC on May 10, 2011)

COMMON STOCK PURCHASE AGREEMENT Dated as of May 10, 2011 by and between OMEROS CORPORATION and AZIMUTH OPPORTUNITY LTD. TABLE OF CONTENTS (Filed With SEC on May 10, 2011)

30 SunnysideAvenue | Mill Valley | CA 94941 | (415) 383-4700 | Fax ###-###-#### (Filed With SEC on May 10, 2011)

SECURED PROMISSORY NOTE (TRANCHE 2 ADVANCE) (Filed With SEC on March 31, 2011)

SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on March 31, 2011)

PLATFORM DEVELOPMENT FUNDING AGREEMENT Dated as of October 21, 2010 among OMEROS CORPORATION, VULCAN INC. and COUGAR INVESTMENT HOLDINGS LLC (Filed With SEC on March 15, 2011)

Life Sciences Discovery Fund LSDF 10-05 Opportunity Grant Grant Award Agreement (Filed With SEC on March 15, 2011)

LOAN AND SECURITY AGREEMENT (Filed With SEC on October 25, 2010)

SECURED PROMISSORY NOTE (CLOSING DATE ADVANCE) (Filed With SEC on October 25, 2010)

OMEROS CORPORATION Common Stock Purchase Warrant (Filed With SEC on October 25, 2010)

Current assets (Filed With SEC on August 10, 2010)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on July 29, 2010)

COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on July 29, 2010)

30 Sunnyside Avenue | Mill Valley | CA 94941 | (415) 383-4700 | Fax ###-###-#### (Filed With SEC on July 29, 2010)

Current assets (Filed With SEC on May 12, 2010)

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers (Filed With SEC on April 12, 2010)

FIRST AMENDMENT (Filed With SEC on March 30, 2010)

FIRST AMENDMENT OF EXCLUSIVE TECHNOLOGY OPTION AGREEMENT (Filed With SEC on November 12, 2009)

obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201 (Filed With SEC on October 2, 2009)

obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201 (Filed With SEC on September 16, 2009)

COMMERCIAL SUPPLY AGREEMENT (Filed With SEC on May 15, 2009)

EXCLUSIVE LICENSE AND SPONSORED RESEARCH AGREEMENT (Filed With SEC on May 15, 2009)

EXCLUSIVE LICENSE AND SPONSORED RESEARCH AGREEMENT between OMEROS CORPORATION and MEDICAL RESEARCH COUNCIL (Filed With SEC on May 15, 2009)

FUNDING AGREEMENT (Filed With SEC on May 15, 2009)

DATED 20 April 2007 (Filed With SEC on May 15, 2009)

AMENDMENT dated 30 April 2007 of the SERVICES AND MATERIALS AGREEMENT dated 20 April 2007 By and between SCOTTISH BIOMEDICAL LIMITED T/A SCOTTISH BIOMEDICAL and OMEROS CORPORATION (Filed With SEC on May 15, 2009)

Drug Product Development and Clinical Supply Agreement (Filed With SEC on May 15, 2009)

MASTER SERVICES AGREEMENT (Filed With SEC on May 15, 2009)

AGREEMENT FOR ANTIBODY DISCOVERY AND DEVELOPMENT (Filed With SEC on May 15, 2009)

EXCLUSIVE TECHNOLOGY OPTION AGREEMENT (Filed With SEC on May 15, 2009)

LOAN AND SECURITY AGREEMENT No. V08302 (Filed With SEC on May 15, 2009)

PROMISSORY NOTE Dated: September 12, 2008 Chicago, Illinois (Filed With SEC on May 15, 2009)

PROMISSORY NOTE Dated: December 23, 2008 Chicago, Illinois (Filed With SEC on May 15, 2009)

OMEROS CORPORATION (Filed With SEC on May 15, 2009)

PATENT ASSIGNMENT AGREEMENT (Filed With SEC on May 15, 2009)

obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201 (Filed With SEC on May 15, 2009)

obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201 (Filed With SEC on April 1, 2008)

obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201 (Filed With SEC on January 9, 2008)

Category

Industry

Companies

Contracts

OMEROS CORP Contracts & Agreements